Authors: Altersberger, Valerian L.; Stolze, Lotte J.; Heldner, Mirjam R.; Henon, Hilde; Martinez-Majander, Nicolas; Hametner, Christian; Nordanstig, Annika; Zini, Andrea; Nannoni, Stefania; Gonçalves, Bruno; Nolte, Christian H.; Baumgartner, Philipp; Kastrup, Andreas; Papanagiotou, Panagiotis; Kägi, Georg; Leker, Ronen R.; Zedde, Marialuisa; Padovani, Alessandro; Pezzini, Alessandro; Padjen, Visnja; Cereda, Carlo W.; Ntaios, Georges; Bonati, Leo H.; Rinkel, Leon A.; Fischer, Urs; Scheitz, Jan F.; Wegener, Susanne; Turc, Guillaume; Michel, Patrik; Gentile, Mauro; Rentzos, Alexandros; Ringleb, Peter A.; Curtze, Sami; Cordonnier, Charlotte; Arnold, Marcel; Nederkoorn, Paul J.; Engelter, Stefan T.; Gensicke, Henrik; null, null

Venue: Stroke

Type: Publication

Abstract: Background and Purpose: Timely reperfusion is an important goal in treatment of eligible patients with acute ischemic stroke. However, during the coronavirus disease 2019 (COVID-19) pandemic, prehospital and in-hospital emergency procedures faced unprecedented challenges, which might have caused a decline in the number of acute reperfusion therapy applied and led to a worsening of key quality measures for this treatment during lockdown. Methods: This prospective multicenter cohort study used data from the TRISP (Thrombolysis in Ischemic Stroke ... (read more)

DOI: 10.1161/strokeaha.120.032176